DOI QR코드

DOI QR Code

HPV Infection and Cervical Abnormalities in HIV Positive Women in Different Regions of Brazil, a Middle-Income Country

  • Freitas, Beatriz C (Laboratory of Clinical Cytology, Department of Clinical Analysis and Biomedicine, State University of Maringa) ;
  • Suehiro, Tamy T (Laboratory of Clinical Cytology, Department of Clinical Analysis and Biomedicine, State University of Maringa) ;
  • Consolaro, Marcia EL (Laboratory of Clinical Cytology, Department of Clinical Analysis and Biomedicine, State University of Maringa) ;
  • Silva, Vania RS (Laboratory of Clinical Cytology, Department of Clinical Analysis and Biomedicine, State University of Maringa)
  • Published : 2016.01.11

Abstract

Human papillomavirus is a virus that is distributed worldwide, and persistent infection with high-risk genotypes (HR-HPV) is considered the most important factor for the development of squamous cell cervical carcinoma (SCC). However, by itself, it is not sufficient, and other factors may contribute to the onset and progression of lesions. For example, infection with other sexually transmitted diseases such as human immunodeficiency virus (HIV) may be a factor. Previous studies have shown the relationship between HPV infection and SCC development among HIV-infected women in many regions of the world, with great emphasis on low- and middle-income countries (LMICs). Brazil is considered a LMIC and has great disparities across different regions. The purpose of this review was to highlight the current knowledge about HPV infection and cervical abnormalities in HIV+ women in Brazil because this country is an ideal setting to evaluate HIV impact on SCC development and serves as model of LMICs and low-resource settings.

Keywords

Human papillomavirus;human immunodeficiency virus;cervical abnormalities;epidemiology;Brazil

References

  1. Adler DA (2010). The impact of HAART on HPV-related cervical disease. Curr HIV Res, 8, 493-7. https://doi.org/10.2174/157016210793499240
  2. Andrade ACVd, Luz PM, Velasque L, et al (2011). Factors associated with colposcopy-histopathology confirmed cervical intraepithelial neoplasia among HIV-infected women from Rio De Janeiro, Brazil. PloS one, 6, 18297. https://doi.org/10.1371/journal.pone.0018297
  3. Araujo ACL, Carvalho NO, Teixeira NC, et al (2012). Incidence of cervical intraepithelial neoplasia in a cohort of HIVinfected women. Int J Gynecol Obstet, 117, 211-6. https://doi.org/10.1016/j.ijgo.2011.12.024
  4. Beachler DC, Abraham AG, Silverberg MJ, et al (2014). Incidence and risk factors of HPV-related and HPV-unrelated head and neck squamous cell carcinoma in HIV-infected individuals. Oral Oncol, 50, 1169-76. https://doi.org/10.1016/j.oraloncology.2014.09.011
  5. Blossom DB, Beigi RH, Farrell JJ, et al (2007). Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women. J Med Virol, 79, 758-65. https://doi.org/10.1002/jmv.20817
  6. Boletim Epidemiologico - Aids e DST (2014). Ministerio da saude - secretaria de vigilancia em saude - departamento de DST, aids e hepatites virais. Brasilia: Brasil.
  7. Brandao VCRAB, Lacerda RL, Ximenes RAA, et al (2010). Frequencia de Papilomavirus humano (HPV) e Chlamydia trachomatis em gestantes. Epidemiol Serv Saude, 19, 43-50.
  8. Correa CM, Teixeira NCP, Araujo ACLd, et al (2011). Prevalence and multiplicity of HPV in HIV women in Minas Gerais, Brazil. Rev Assoc Med Bras, 57, 425-30. https://doi.org/10.1590/S0104-42302011000400017
  9. De Sanjose S, Quint WGV, Alemany L, et al (2010). Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol, 11, 1048-56. https://doi.org/10.1016/S1470-2045(10)70230-8
  10. Denny LA, Franceschi S, de Sanjose S, et al (2012). Human Papillomavirus, Human Immunodeficiency Virus and Immunosuppression. Vaccine, 5, 168-74.
  11. Entiauspe LG, Teixeira LO, Mendoza-Sassi RA, et al (2010). Papilomavirus humano: prevalencia e genotipos encontrados em mulheres HIV positivas e negativas, em um centro de referencia no extremo Sul do Brasil. Rev Soc Bras Med Trop, 43, 260-3. https://doi.org/10.1590/S0037-86822010000300009
  12. Fedrizzi EN, Laureano JK, Schlup C, et al (2011). Infeccao pelo papilomavirus humano (HPV) em mulheres HIV-positivo de Florianopolis, Santa Catarina. DST J Bras Doencas Sex Transm, 23.
  13. Felix G, Ceolim MF (2012). O perfil da mulher portadora de HIV/AIDS e sua adesao a terapeutica antirretroviral. Rev Esc Enferm USP, 46, 884-91. https://doi.org/10.1590/S0080-62342012000400015
  14. Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917. https://doi.org/10.1002/ijc.25516
  15. Firnhaber C, Evans D, Friedman-Khalili R, et al (2011). Seroprevalence of HPV vaccine types 6, 11, 16 and 18 in HIV-infected women from South Africa, Brazil and Botswana. J Clin Virol, 52, 265-8. https://doi.org/10.1016/j.jcv.2011.08.011
  16. Instituto Nacional de Cancer - INCA (2014). Incidencia de Cancer no Brasil, estimativa 2014. Rio de Janeiro, RJ, Brasil.
  17. Instituto Nacional de Cancer - INCA (2014). Estimativas: Neoplasia maligna do colo do utero.
  18. International Agency for Research on Cancer (IARC) - World Health Organization (2012). Cervical Cancer: Estimated Incidence, Mortality and Prevalence Worldwide in 2012.
  19. International Agency for Research on Cancer (IARC) - World Health Organization (2011). Monographs on the evaluation of carcinogenic risk to humans. Volume 100B: A review of human carcinogens: biological agents. Lyon - France.
  20. Jalil EM, Bastos FI, Melli PP, et al (2013). HPV clearance in postpartum period of HIV-positive and negative women: a prospective follow-up study. BMC Infectious Diseases, 13, 564. https://doi.org/10.1186/1471-2334-13-564
  21. Joura EA, Giuliano AR, Iversen OE, et al (2015). A 9-Valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med, 372, 711-23. https://doi.org/10.1056/NEJMoa1405044
  22. Koh WJ, Greer BE, Abu-Rustum NR, et al (2015). Cervical cancer, version 2.2015. JNCCN, 13, 395-404.
  23. Kurman RJ, Ellenson LH, Ronnett BM (2011). Blaustein's Pathology of the female genital tract, 6th edn. New York: Springer Verlag, 1246.
  24. Lima MDM, Braz-Silva PH, Pereira SM, et al (2014). Oral and cervical HPV infection in HIV-positive and HIV-negative women attending a sexual health clinic in Sao Paulo, Brazil. Int J Gynecol Obstet, 126, 33-6. https://doi.org/10.1016/j.ijgo.2014.01.017
  25. Luque AE, Hitti J, Mwachari C, et al (2010). Prevalence of human Papillomavirus genotypes in HIV-1-infected women in Seattle, USA and Nairobi, Kenya: results from the Women's HIV Interdisciplinary Network (WHIN). J Infect Dis, 14, 810-804.
  26. Marur S, D'Souza G, Westra W, et al (2010). HPV-associated head and neck cancer: a virus related cancer epidemic. Lancet Oncol, 11, 781-9. https://doi.org/10.1016/S1470-2045(10)70017-6
  27. Mattos ATd, Freitas LBd, Lima BMC, et al (2011). Diversity and uncommon HPV types in HIV seropositive and seronegative women attending an STI clinic. Braz J Microbiol, 42, 786-93. https://doi.org/10.1590/S1517-83822011000200047
  28. McKenzie ND, Kobetz EN, Hnatysyn J, et al (2010). Women with HIV are more commonly infected with non-16 and -18 high-risk HPV types. Gynecol Oncol, 116, 572-7. https://doi.org/10.1016/j.ygyno.2009.10.058
  29. Melgaco FG, Rosa MLG, Augusto EF, et al (2011). Human papillomavirus genotypes distribution in cervical samples from women living with human immunodeficiency virus. Arch Gynecol Obstet, 283, 809-17. https://doi.org/10.1007/s00404-010-1443-z
  30. Meyrelles ARI, Siqueira JD, Hofer CB, et al (2013). HIV/ HPV co-infection during pregnancy in southeastern Brazil: Prevalence, HPV types, cytological abnormalities and risk factors. Gynecol Oncol, 128, 107-12. https://doi.org/10.1016/j.ygyno.2012.10.003
  31. Oliveira PM, Oliveira RPC, Travessa IEM, et al (2010). Prevalence and risk factors for cervical intraepithelial neoplasia in HIV-infected women in Salvador, Bahia, Brazil. Sao Paulo Med J, 128, 197-201. https://doi.org/10.1590/S1516-31802010000400004
  32. Ortiz AP, Perez-Irizarry J, Soto-Salgado M, et al (2014). Human papillomavirus-related cancers among people living with AIDS in Puerto Rico. Prev Chronic Dis, 11, 80.
  33. Paim J, Travassos C, Almeida C, et al (2011). The Brazilian health system: history, advances, and challenges. Lancet, 377, 1778-97. https://doi.org/10.1016/S0140-6736(11)60054-8
  34. Paulo M, Borges AB, Duarte G, et al (2007). The environmental cofactors in carcinogenesis in high risk HPV/HIV-positive women. Braz J Infect Dis, 11, 189-95. https://doi.org/10.1590/S1413-86702007000200003
  35. Piketty C, Selinger-Leneman H, Bouvier A-M, et al (2012). Incidence of HIV-related anal cancer remains increased despite long-term combined antiretroviral treatment: results from the French hospital database on HIV. Clin Oncol, 30, 4360-6. https://doi.org/10.1200/JCO.2012.44.5486
  36. Portal Brasil (2015). Mortalidade de AIDS cai 13% nos ultimos 10 anos no Brasil.
  37. Portal Brasil (2015). Relatorio contabiliza casos de HIV/AIDS na America Latina.
  38. Requejo HIZ (2006). Worldwide molecular epidemiology of HIV. Rev Saude Publica, 40, 331-45. https://doi.org/10.1590/S0034-89102006000200023
  39. Rocha-Brischiliari SC, Gimenes F, de Abreu ALP, et al (2014). Risk factors for cervical HPV infection and genotypes distribution in HIV-infected South Brazilian women. Infec Agents Cancer, 9, 1-6. https://doi.org/10.1186/1750-9378-9-1
  40. Rosa MI, Fachel JM, Rosa DD, et al (2008). Persistence and clearance of human papillomavirus infection: a prospective cohort study. Am J Obstet Gynecol, 199, 617.
  41. Santos NJS, Barbosa RM, Pinho AA, et al (2009). Contextos de vulnerabilidade para o HIV entre mulheres brasileiras. Cad Saude Publica, 25, 321-33. https://doi.org/10.1590/S0102-311X2009000200010
  42. Shrestha S, Sudenga SL, Smith JS, et al (2010). The impact of highly active antiretroviral therapy on prevalence and incidence of cervical human papillomavirus infections in HIV-positive adolescents. BMC Infect Dis, 10, 295. https://doi.org/10.1186/1471-2334-10-295
  43. Smith-McCune KK, Shiboski S, Chirenje MZ, et al (2010). Type-specific cervico-vaginal human papillomavirus infection increases risk of HIV acquisition independent of other sexually transmitted infections. PloS one, 5, 10094. https://doi.org/10.1371/journal.pone.0010094
  44. Solomon D, Nayar R (2005). Sistema Bethesda para citopatologia cervicovaginal: definicoes, criterios e notas explicativas: Revinter.
  45. Spangler JM, Munger K (2010). The human Papillomavirus type 16 E6 oncoprotein activates mTORC1 signaling and increases protein synthesis. J Virol, 84, 9398-407. https://doi.org/10.1128/JVI.00974-10
  46. Stier E (2009). Human papillomavirus related diseases in HIVinfected individuals. Curr Opin Oncol, 20, 541-6.
  47. Sudenga SL, Wiener HW, King CC, et al (2014). Dense genotyping of immune-related loci identifies variants associated with clearance of HPV among HIV-positive women in the HIV epidemiology research study (HERS). Plos One, 9, 99109. https://doi.org/10.1371/journal.pone.0099109
  48. Teixeira NCP, Araujo ACL, Correa CM, et al (2012). Prevalence and risk factors for cervical intraepithelial neoplasia among HIV-infected women. Braz J Infect Dis, 16, 164-9. https://doi.org/10.1016/S1413-8670(12)70299-4
  49. Tornatore M, Goncalves CV, Bianchi MS, et al (2012). Coinfections associated with human immunodeficiency virus type 1 in pregnant women from southern brazil: high rate of intraepithelial cervical lesions. Mem Inst Oswaldo Cruz, 107, 205-10. https://doi.org/10.1590/S0074-02762012000200009
  50. Vaz LP, Saddi VA, Amaral WNd, et al (2011). Epidemiologia da infeccao pelo HPV em mulheres infectadas pelo HIV. Femina, 39, 35-40.

Cited by

  1. Sociodemographic determinants of abnormal cervical cytology among HIV positive women in Nnewi, Nigeria vol.9, pp.10, 2017, https://doi.org/10.5897/IJMMS2017.1322